Zaynich antibiotic: How Wockhardt created India\'s first FDA-approved drug | Pharma Industry
2026-06-15 18:12:00Zaynich antibiotic: How Wockhardt created India\'s first FDA-approved drug | Pharma Industry Business Standard...
Read MoreWockhardt Ltd eases for fifth straight session
2026-06-10 13:50:44Wockhardt Ltd eases for fifth straight session Business Standard...
Read MoreWockhardt Ltd leads losers in \'A\' group
2026-06-05 15:04:01Wockhardt Ltd leads losers in \'A\' group Business Standard...
Read MoreWockhardt Ltd leads losers in \'A\' group
2026-06-05 15:04:01Wockhardt Ltd leads losers in \'A\' group Business Standard...
Read MoreWockhardt R&D Shift: Dr Khorakiwala On How Zaynich Success Transforms Biotech Capital Allocation
2026-06-03 12:37:08Wockhardt R&D Shift: Dr Khorakiwala On How Zaynich Success Transforms Biotech Capital Allocation Business Today...
Read MoreWockhardt Shares Hit Record High As It Secures USFDA Approval For A Novel Antibiotic Zaynich
2026-06-02 15:02:26Wockhardt Shares Hit Record High As It Secures USFDA Approval For A Novel Antibiotic Zaynich Business Today...
Read MoreWockhardt corrects after blockbuster run on antibiotic approval
2026-06-02 14:50:29Wockhardt corrects after blockbuster run on antibiotic approval Business Standard...
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
11-Jun-2026 | Source : BSEPursuant to Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations 2015 as amended and in continuation to our letter bearing reference no. Ref.no. WOCK/SEC/SE/2025-26/015 dated 1st June 2026 please find enclosed the transcript of the Investor Meeting held on Thursday 4th June 2026 for your information and records.
Announcement under Regulation 30 (LODR)-Investor Presentation
04-Jun-2026 | Source : BSEPursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed herewith copy of the Investor Presentation to be made at the Investor Meeting scheduled to be held on 4th June 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
01-Jun-2026 | Source : BSEPursuant to Regulation 30 of the SEBI(LODR) Regulations 2015 we wish to inform you that the Company will hold an Investor Meet on Thursday 4th June 2026 at 4:00 pm IST.
Corporate Actions
No Upcoming Board Meetings
Wockhardt Ltd has declared 200% dividend, ex-date: 17 Nov 16
No Splits history available
No Bonus history available
Wockhardt Ltd has announced 3:10 rights issue, ex-date: 08 Mar 22